Investors

At this page you will find information about Arcomas business and financial position. The information at this page is aimed at shareholders and potential investors.

Arcomas VD, Sanna Rydberg, och Product Manager, Linda Ungsten, presenterar företaget på Erik Penser Banks temadag

Den 7 oktober höll Erik Penser Bank en temadag om Medicinteknisk mjukvara. Arcomas VD, Sanna Rydberg, och Product Manager, Linda Ungsten, var på plats och presenterade företaget.  Här kan du se hela deras presentation. Vill du se alla talare hittar du deras presentationer här →

Interested in investing in Arcoma?

See our company presentation and learn more about Arcoma and our market.

Investor news


Affärsvärldens senaste analys av Arcoma

“Första halvåret 2021 var det bästa sedan 2015 för medicinteknikbolaget Arcoma. Kan ledningen få igång tillväxten i USA tillsammans med bolag…

Senaste analysen av Arcoma – Tillväxten fortsätter i Q2

“Vi ser att Arcoma är attraktivt positionerat med samarbetsavtal med stora aktörer som medför spridning i stora marknader i Europa och USA. S…

Arcomas presentation från Erik Penser bank temadag 25 maj

Den 25 maj presenterade Sanna Rydberg Arcoma på Erik Penser Banks temadag om Medicinsk Bildteknik & Diagnostik. Presentationen kan ses i efterh…

Arcoma – Intäkter växer under Q1

Arcoma redovisar intäkter för Q1 om 36,9 mkr (+ 10 % y/y) mot våra estimat om 35 mkr. Rörelseresultatet var 1,9 mkr mot förväntade 3,6 mkr, vilket …

Årsredovisning 2020 är nu publicerad

Arcoma publicerar idag sin årsredovisning för verksamhetsåret 2020 på bolagets hemsida www.arcoma.se/about-us/investors. Läs pressrelease

Company presentations & interviews

  • 2021-10-07: Sanna Rydberg och Linda Ungsten presenterar Arcoma på Erik Penser Banks temadag om Medicinteknisk mjukvara. Se presentationen.
  • Årsstämma 2020 – Sanna Rydberg, VD Arcoma sammanfattar 2020 och blickar framåt. Se video
  • 2021-05-25: Sanna Rydberg presenterar Arcoma på Erik Penser Banks temadag om Medicinsk Bildteknik & Diagnostik. Se presentationen.
  • 2021-02-22: Arcomas VD Sanna Rydberg intervjuas av aktieanalytiker Hjalmar Jernström på Erik Penser Bank. Länk till video.
  • 2020-11-25: Den 25 november 2020 presenterade Arcomas nya VD, Sanna Rydberg bolaget på Erik Penser Banks bolagsdag samt deltog på en intervju. Länk till Presentation och intervju. 

  • 2020-03-12: Arcoma presenterar på Stockholm Corporate Finance (SCF) tolfte Life Science-seminarium. Videosändning

Board of directors

Lars Kvarnhem – Chairman

Lars Kvarnhem, born in 1972, has approximately 20 years of experience in global management and business development of companies and business processes within the MedTech industry.

Previous operational roles have been, among others:

  • CEO and main owner of the MedTech company Anmedic AB, active in anesthesia and intensive Care.
  • President and CEO for Human Care (publ) in healthcare products.
  • Operational Chairman of the MedTech division at Medcap (publ).

Works exclusively as an investor, primarily in the field of Medical Technology. Today Lars holds several board assignments which includes chairman of the board of Arcoma AB (publ), Stille (publ), Absorbets AB, Absorbest Holding AB, Swevet AB, Swevet Holding AB, Reison Medical AB, Part Production AB, Priego AB and Ovon AB, better known as MrCap. Board member Cavis Technologies.

Year of birth 1972
Chairman since 2017
Shares 1 299 425 (1 299 425) through Priego AB

Other assignments: Chairman of the board of Swevet AB, Reison Medical AB and Ovon AB, better known as MrCap.

Lars is dependent in relation to major shareholders.

Mats Thorén – Board member

Mats Thorén has extensive experience in the medical technology sector, including with Handelsbanken Capital Markets as an account executive for the health sector in Corporate Finance, as an analyst in the biotechnology and medical technology at Enskilda Securities as well as Partner at Catella Healthcare AB. Previous board appointments include inter alia C-Rad AB, Cellartis AB and MIP Technologies AB.

Year of birth 1971
Member/deputy 2012/2010
Shares 666 100 directly and through Vixco Capital AB Independent in relation to major shareholders

Other assignments Board member of: Pulsetten AB, Vixco Capital AB, Arcoma Incentive AB and board substitute for Eggelbertus Holding AB.

Mats is independent in relation to major shareholders.

Jesper Söderqvist – Board member

Jesper Söderqvist is currently the CEO for Boule Diagnostics AB and were previosly the CEO for Arcoma AB (feb 2018 – maj 2020). Jesper has more than 14 years of experience from Life Science, radiology and radiation therapy, including as Vice President Portfolio Management at Elekta and CEO of Sectra AB’s subsidiary Sectra Mamea AB. Jesper holds a Master of Science in engineering physics and a PhD in particle physics both from Royal Institute of Technology.

Year of birth 1966
Member since 2020
Shares 75 000
Other assignments Board member for Biovica International AB and Dekatria AB.

Jesper is independent in relation to major shareholders.

Management team

Sanna Rydberg – Verkställande Direktör

Sanna Rydberg har ca 20 års erfarenhet från ledande positioner, senast som VD för Eurofins BioPharma Product Testing Sweden AB där hon varit anställd som VD. Verksamheten omfattar kemiska och mikrobiologiska analyser till Läkemedel- och Medicinteknikbolag.

Dessförinnan som verksamhetschef för Healthcare Nordeuropa på Linde (tidigare AGA). Verksamheten omfattade hela kedjan från tillverkning till försäljning och distribution av både läkemedel och medicintekniska produkter. Samt två kliniker för vård av patienter med respiratoriska problem.

Sanna Rydberg har en Fil.kand. i Analytisk Kemi, Uppsala Universitet.

Sanna är även ledamot i styrelsen för Observe Medical ASA.

Year of birth 1969
Employed since 2020
Other assignments None
Own and related party shares 7000
Contact info sanna.rydberg@arcoma.se

Carina Kenneman – Interim CFO

Carina Kenneman has a Degree of Bachelor of Science in Business Administration and Economics from Stockholm University, audit background and long experience of the role as Financial Manager in various operations.

Year of birth 1968
Interim since 2021
Other assignments None
Own and related party shares 0
Contact info carina.kenneman@arcoma.se

Johan Henningsson – R&D Manager

Johan Henningsson has a bachelor in mechanical engineering at Linné University. Johan has a background as a mechanical engineer at Arcoma.

Year of birth 1971
Employed since 1994, in current position since 2014.
Other assignments None
Own and related party shares 7254
Contact info johan.henningsson@arcoma.se

Linda Ungsten – Product Manager

Linda holds a Master of Science in Engineering from Linköping University of Technology and experience as product manager at Bombardier Transportation and from employment within Radiological Physics at Sahlgrenska University Hospital.

Year of birth 1974
Employed since 2008, in her current position since 2011
Other assignments None
Own and related party shares None
Contact info linda.ungsten@arcoma.se

Nicklas Johansson – Operations Manager

Nicklas Johansson has background as manufacturing manager, and workshop manager at Fläkt Woods and production planner at Arcoma AB.

Year of birth 1967
Employed since 2003, in current position since 2016
Other assignments None
Own and related party shares 14 000
Contact info nicklas.johansson@arcoma.se

Frida Robbe – Marketing Manager

Frida Robbe is educated in marketing, web development, graphic design and copywriting and has experience from marketing of medical and healthcare products for more than 10 years.

Year of birth 1985
Employed since 2019
Other assignments None
Own and related party shares 280
Contact info frida.robbe@arcoma.se

Jesper Lindroos – Purschasing Manager

Jesper Lindroos has extensive experience from the medical technology and manufacturing industry and comes most recently from Getinge Group where he held the position as Chief Project Manager. He has a Master of Science in Mechanical Engineering from Lund University and joined Arcoma during 2020.

Year of birth 1984
Employed since 2020
Other assignments None
Own and related party shares None
Contact info jesper.lindroos@arcoma.se

Henrik Blomdahl – Quality Manager

Henrik Blomdahl has over 20 years of experience in the medical technology industry. Most recently, Henrik comes from Invacare Rea AB, where he had the role of QA/RA Manager Nordics.

Prior to that he worked as a quality technician at Getinge Disinfection in Växjö, focusing on supplier quality, project management and internal and external audits.

Employed since 2021
Other assignments None
Own and related party shares None
Contact info henrik.blomdahl@arcoma.se

Share information

According to Articles of Association of Arcoma AB:

  • The share capital shall not be less than 12 000 000 Kronor and no more then 48 000 000 Kronor.
  • The number of shares shall not be less than 6 000 000 shares and no more then 24 000 000 shares.
  • Registered share capital is 25 624 120 kronor.
  • The shares is issued under the Companies Act and is denominated in Swedish kronor.
  • There is only one type of share. All shares carry equal rights to the Company’s assets and results, and are entitled to one vote at the Annual General Meeting. One share equals one vote.
  • Company’s share register is kept by Euroclear Sweden AB (former VPC AB), Box 7822, 103 97 Stockholm. Shareholders of the Company will receive no physical share. All transactions with the Company’s shares are done electronically through authorized banks and broker- dealers. Newly issued shares will be registered in person in electronic format.
  • Issuer and the account operator is Erik Penser Bank, Apelbergsgatan 27, Box 7405, 103 91 Stockholm
  • The shares ISIN-Code is SE0006219176
  • The LEI code is 549300C0DH9EESDQUA52

Shareholders

Register Date: 2021-06-30

Main Share
Holders

 

Percentage of
issued shares

Linc AB

 

25,25%

Sunstone Life Science Ventures Fund II K/S

 

25,04%

Priego AB

 

10,01%

Avanza Pension

  5,91%

Mats Thorén via bolag

  5,04%
     
     

    We develop, produce and provide complete radiology solutions worldwide with the mission to improve care for the patient and work environment for the user.